Who owns KARYOPHARM THERAPEUTICS INC COM NEW?
- Ticker: KPTI
- CUSIP Number: 48576u205
Tip: Access positions for across all investors
Analyze quarterly positions in Karyopharm Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Karyopharm Therapeutics stock
Who bought or sold KARYOPHARM THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management | 701k | $4.6M | -4% | Sep 2025 |
|
| Adage Capital Partners GP | 421k | $2.8M | 0% | Sep 2025 |
|
| Vanguard Group | 408k | $2.7M | -21% | Sep 2025 |
|
| Susquehanna International | 282k | $1.8M | 1599% | Sep 2025 |
|
| BlackRock | 232k | $1.5M | -2% | Sep 2025 |
|
| Affinity Asset Advisors | 158k | $1.0M | 0% | Sep 2025 |
|
| Catalio Capital Management | 143k | $935k | 100% | Sep 2025 |
|
| Avidity Partners Management | 135k | $880k | 0% | Sep 2025 |
|
| Marshall Wace | 129k | $840k | 0% | Sep 2025 |
|
| CAM Group Holding A/S | 100k | $654k | 0% | Sep 2025 |
|
| Geode Capital Management | 93k | $610k | 2% | Sep 2025 |
|
| Citadel Advisors | 92k | $602k | -59% | Sep 2025 |
|
| Group One Trading | 68k | $448k | -30% | Sep 2025 |
|
| Renaissance Technologies | 65k | $423k | -2% | Sep 2025 |
|
| UBS Group | 60k | $390k | -63% | Sep 2025 |
|
| State Street Corporation | 46k | $303k | 39% | Sep 2025 |
|
| Silverback Asset Management | 40k | $262k | -43% | Sep 2025 |
|
| Bridgeway Capital Management | 35k | $228k | -8% | Sep 2025 |
|
| Ikarian Capital | 27k | $178k | 0% | Sep 2025 |
|
| Baird Financial | 26k | $170k | 146% | Sep 2025 |
|
| Morgan Stanley | 25k | $108k | 100% | Jun 2025 |
|
| ADAR1 Capital Management | 25k | $164k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 25k | $163k | -71% | Sep 2025 |
|
| Northern Trust | 19k | $123k | 0% | Sep 2025 |
|
| Belvedere Trading | 15k | $99k | 100% | Sep 2025 |
|
| XTX Topco | 14k | $94k | 10% | Sep 2025 |
|
| GSA Capital Partners | 14k | $92k | 1% | Sep 2025 |
|
| Jane Street | 13k | $84k | 100% | Sep 2025 |
|
| Bank of New York Mellon | 11k | $73k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 6.7k | $44k | -9% | Sep 2025 |
|
| Simplex Trading | 5.9k | $38k | -29% | Sep 2025 |
|
| Barclays | 4.1k | $27k | -23% | Sep 2025 |
|
| TD Waterhouse Canada | 3.2k | $20k | 0% | Sep 2025 |
|
| Tower Research Capital | 1.1k | $7.1k | 28% | Sep 2025 |
|
| FMR | 679.00 | $4.4k | -11% | Sep 2025 |
|
| Jpmorgan Chase & Co | 550.00 | $3.6k | -100% | Sep 2025 |
|
| Advisor Group Holdings | 346.00 | $2.3k | 0% | Sep 2025 |
|
| Quent Capital | 231.00 | $1.5k | 100% | Sep 2025 |
|
| Rise Advisors | 131.00 | $857.002000 | 100% | Sep 2025 |
|
| Mb, Levis & Associates | 100.00 | $654.000000 | 0% | Sep 2025 |
|
| Harbour Investments | 85.00 | $556.002000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 82.00 | $536.001200 | -100% | Sep 2025 |
|
| Fortitude Family Office | 81.00 | $529.999200 | 0% | Sep 2025 |
|
| SBI Securities | 74.00 | $483.997000 | 0% | Sep 2025 |
|
| Activest Wealth Management | 66.00 | $432.003000 | 0% | Sep 2025 |
|
| Hanson McClain Advisors | 26.00 | $170.999400 | -19% | Sep 2025 |
|
| Bruce G. Allen Investments | 22.00 | $144.001000 | 0% | Sep 2025 |
|
| Advisory Services Network | 12.00 | $78.000000 | 100% | Sep 2025 |
|
| Pittenger & Anderson | 3.00 | $20.000100 | 100% | Sep 2025 |
|
| Atlantic Trust | 3.00 | $20.000100 | 0% | Sep 2025 |
|
| West Branch Capital | 3.00 | $20.000100 | 0% | Sep 2025 |
|
Who sold out of Karyopharm Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Eversept Partners | Jun 2025 | 257k | $1.1M |
| Palo Alto Investors | Jun 2025 | 188k | $810k |
| Millennium Management | Jun 2025 | 32k | $137k |
| Raymond James Financial | Jun 2025 | 90.00 | $387.855000 |